In addition, a study on ovarian cancer found that another FZD family member, FZD7, can protect cells from chemotherapy-induced oxidative stress through the FZD7–β-catenin–Tp63–GPX4 pathway (Wang et al., 2021b). This evidence concerns the gene FZD7 and ovarian carcinoma.